Early adenovirus-mediated gene transfer effectively prevents muscular dystrophy in alpha-sarcoglycan-deficient mice

Gene Therapy

Volumn 7, Issue 16, 2000, Pages 1385-1391

  Allamand, V ^a   Donahue, K M ^b   Straub, V ^a   Davisson, R L ^a   Davidson, B L ^a   Campbell, K P ^a  

^a UNIVERSITY OF IOWA   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Adenovirus; Gene transfer; Limb girdle muscular dystrophy; Murine model; Sarcoglycan

Indexed keywords

SARCOGLYCAN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; LIMB GIRDLE MUSCULAR DYSTROPHY; MORPHOLOGY; MOUSE; MUSCLE CELL; MUSCLE FUNCTION; NEWBORN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SARCOLEMMA; SKELETAL MUSCLE;

ADENOVIRIDAE; ANIMALIA; MURINAE;

EID: 0033843869     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301247     Document Type: Article

References (40)

1. Membrane organization of the dystrophin-glycoprotein complex
2. Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl, β-D-glucoside
3. Sarcospan: The 25 kDa transmembrane component of the dystrophin-glycoprotein complex
4. Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan complex
5. Association of dystrophin and an integral membrane glycoprotein
6. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle
7. Glycoprotein complex anchoring dystrophin to the sarcolemma
8. Assembly of the sarcoglycan complex
9. Missense mutations in the Adhalin gene linked to autosomal recessive muscular dystrophy
10. β-sarcoglycan mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex
11. β-Sarcoglycan: Characterization and role in limb-girdle muscular dystrophy linked to 4q12
12. Mutations in the dystrophin-associated protein γ-sarcoglycan in chromosome 13 muscular dystrophy
13. Mutations that disrupt the carboxyl-terminus of γ-sarcoglycan cause muscular dystrophy
14. Identification of a novel sarcoglycan gene at 5q33 encoding a sarcolemmal 35 kDa glycoprotein
15. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ-sarcoglycan gene
16. The limb-girdle muscular dystrophies-multiple genes, multiple mechanisms
17. The sarcolgycan complex in limb-girdle muscular dystrophy
18. Primary adhalinopathy: A common cause of autosomal recessive muscular dystrophy of variable severity
19. Mutational diversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D)
20. Seven autosomal recessive limb-girdle muscular dystrophies in the Brazilian population: From LGMD2A to LGMD2G
21. Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using δ-sarcoglycan gene transfer
22. Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector
23. rAAV vector-mediated sarcoglycan gene transfer in a hamster model for limb girdle muscular dystrophy
24. Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice
25. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption
26. Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells
27. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy
28. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression
29. Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver
30. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors
31. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle
32. Adenovirus-mediated gene transfer: Influence of transgene, mouse strain and type of immune response on persistence of transgene expression
33. Transduction of dendritic cells by DNA viral vectors directs the immunre response to transgene products in muscle fibers
34. Myosin isoform transitions and physiological properties of regenerated and re-innervated sole muscles of the rat
35. Contrast agent-enhanced magnetic resonance imaging of skeletal muscle damage in animal models of muscular dystrophy
36. Expression of Coxsackie adenovirus receptor and alpha(v)-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers
37. Next-generation adenoviral vectors: New and improved
38. Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice
39. Disruption of the β-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E
40. Persistence in muscle of an adenoviral vector that lacks all viral genes